Affordable Access

Intermediate-dose methotrexate and intravenous 6-mercaptopurine chemotherapy for children with acute lymphoblastic leukemia who did not respond to initial induction therapy.

Authors
  • Ogden, Angela K
  • Pollock, Brad H
  • Bernstein, Mark L
  • Camitta, Bruce
  • Buchanan, George R
Type
Published Article
Journal
Journal of Pediatric Hematology/Oncology
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Jan 01, 2002
Volume
24
Issue
3
Pages
182–187
Identifiers
PMID: 11990303
Source
Medline
License
Unknown

Abstract

Intermediate-dose intravenous methotrexate and intravenous 6-mercaptopurine can induce remission in some patients with ALL who experience initial induction failure. Features predicting complete remission, however, could not be identified.

Report this publication

Statistics

Seen <100 times